Under the umbrella of EuroNanoMed III (official website), the 10th Joint Transnational Call will be launched for funding multilateral innovative research projects on nanomedicine.
- This call is likely to open on: 14th November 2018
- Submission deadline for pre-proposals: 31st January 2019
- Submission deadline of full proposals: 1st July 2019
AIMS OF THE CALL
EuroNanoMed aims (i) to support translational research projects that combine innovative approaches in the field of nanomedicine and; (ii) to encourage and enable transnational collaboration between public and private research groups from academia, clinical/public health research or research teams from industrial enterprises (all size). The participation of Medical Doctors and SMEs is strongly encouraged.
TOPICS OF THE CALL
Project proposals will address multidisciplinary and translational research. Project proposals will need to cover at least one of the following areas that are equal in relevance for this call:
- Regenerative medicine
- Targeted delivery systems
The projects should fall within Technology Readiness Levels (TRL)1 3-6, although for being realistic and coherent with the characteristics of the call, projects should propose advancements for a maximum of two TRL levels during their lifetime.
POTENTIAL PARTICIPATING COUNTRIES AND REGIONS
Bulgaria, Canada (Quebec), Czech Republic, Estonia, France, Greece, Italy, Latvia, Lithuania, Norway, Poland, Romania, Slovakia, Spain, Taiwan and Turkey (see the contact list in the preliminary announcement).
Looking for partners?
Have a look at the European Nanomedicine Map!
- Ignacio Baanante
- +34 9182 22576
About EuroNanomed III
EuroNanoMed (ENM) is an ERA-NET on Nanomedicine established since 2008 as a platform for funding agencies and ministries to coordinate research and innovation programmes with the goal of creating and funding collaborative research and innovation projects that can convert research in nanotechnology into practical gains in medicine. Through 9 successful Joint Transnational Calls launched from 2009 to 2018, ENM has allocated about 75,4 Million euros to fund 87 transnational and innovative research projects in nanomedicine.
EuroNanoMed III is funded under the ERA-NET Cofund scheme of the Horizon 2020 Research and Innovation Framework Programme of the European Commission, Research Directorate-General, Grant Agreement No. 723770